Ask Warren

Daihan Scientific

131220 · KOSDAQ · ₩131220 · 대한과학

₩3,720▼ ₩15 (0.40%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩22B₩18B₩25B₩21B₩19B₩16B₩22B₩18B
Cost of sales₩15B₩12B₩19B₩15B₩13B₩11B₩16B₩13B
Gross profit₩6.3B₩5.3B₩5.8B₩6.3B₩5.5B₩4.8B₩5.5B₩5.1B
Operating income₩2.1B₩973M₩601M₩2.3B₩1.7B₩928M₩1.3B₩1.2B
Net income₩944M₩917M₩2.4B₩941M₩599M₩824M₩2.7B₩294M
Net income to shareholders₩1.3B₩549M₩44M₩1.7B₩1B₩523M₩905M₩715M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩73B₩71B₩72B₩70B₩67B₩68B₩68B₩63B
Current assets₩54B₩51B₩53B₩51B₩47B₩48B₩47B₩44B
Cash and equivalents₩3.4B₩3.5B₩5B₩3B₩3.6B₩2.3B₩5.4B₩1.7B
Total liabilities₩15B₩14B₩15B₩14B₩13B₩15B₩15B₩12B
Current liabilities₩13B₩13B₩14B₩13B₩12B₩14B₩14B₩12B
Borrowings₩4.9B₩434M₩170M₩166M₩183M₩1.9B₩1.5B₩1.5B
Total equity₩58B₩57B₩57B₩57B₩54B₩53B₩53B₩51B
Shareholders' equity₩46B₩45B₩45B₩45B₩43B₩42B₩42B₩40B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩1.4B−₩204M₩3.6B₩361M₩3B−₩1.5B₩5.7B₩650M
Capital spending₩106M₩116M₩74M₩175M₩55M₩11M₩94M₩52M
Free cash flow₩1.3B−₩320M₩3.5B₩186M₩3B−₩1.5B₩5.6B₩597M
Dividends paid₩991M₩279M₩0₩44M₩421M₩225M₩49M₩0

Consolidated where available. Amounts in won.

Also known as: Daihan Scientific / 대한과학 / 131220 / KRX:131220

Source: KRX statistical information